TENCENT
00700
TME-SW
01698
XIAOMI-W
01810
ALI HEALTH
00241
KUAISHOU-W
01024
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | -1.35%559.47M | ---- | 188.53%567.14M | ---- | 9.22%196.56M | ---- | 2.15%179.97M | ---- | 25.38%176.17M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | -201.85%-17.95M | ---- | -259.55%-5.95M | ---- | 81.84%-1.65M | ---- | 54.39%-9.11M | ---- | 23.20%-19.97M |
Interest expense - adjustment | ---- | 113.07%131.46M | ---- | 24.19%61.7M | ---- | 21.51%49.68M | ---- | 99.79%40.89M | ---- | -36.26%20.47M |
Attributable subsidiary (profit) loss | ---- | -15.79%-605.99M | ---- | -155.21%-523.36M | ---- | -267.61%-205.07M | ---- | 27.35%-55.78M | ---- | -18.76%-76.79M |
Impairment and provisions: | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -200.00%-1.77M | ---- | 124.67%1.77M |
-Impairmen of inventory (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -200.00%-1.77M | ---- | 124.67%1.77M |
Revaluation surplus: | ---- | 107.58%6.03M | ---- | 170.55%2.9M | ---- | 225.50%1.07M | ---- | -214.34%-855K | ---- | ---272K |
-Fair value of investment properties (increase) | ---- | 107.58%6.03M | ---- | 170.55%2.9M | ---- | 225.50%1.07M | ---- | -214.34%-855K | ---- | ---272K |
Asset sale loss (gain): | ---- | ---- | ---- | --5K | ---- | ---- | ---- | ---- | ---- | ---- |
-Loss (gain) from selling other assets | ---- | ---- | ---- | --5K | ---- | ---- | ---- | ---- | ---- | ---- |
Depreciation and amortization: | ---- | 1.46%1.88M | ---- | 0.54%1.85M | ---- | -4.11%1.84M | ---- | -23.24%1.92M | ---- | 39.89%2.5M |
Operating profit before the change of operating capital | ---- | -28.19%74.9M | ---- | 145.73%104.3M | ---- | -72.66%42.44M | ---- | 49.46%155.26M | ---- | 36.32%103.89M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | -583.11%-605.54M | 542.56%1.35B | -79.26%125.34M | -1,362.54%-305.32M | 38.19%604.25M | 107.47%24.18M | 144.92%437.27M | 56.30%-323.59M | -1,250.07%-973.39M | -834.90%-740.45M |
Accounts receivable (increase)decrease | -55.80%-382.08M | 53.61%-112.85M | 21.72%-245.24M | -192.36%-243.29M | -272.49%-313.26M | 212.11%263.4M | 276.20%181.61M | -331.50%-234.95M | -237.38%-103.07M | ---54.45M |
Accounts payable increase (decrease) | 335.90%308.27M | -141.73%-238.92M | -66.38%70.72M | 1,170.87%572.58M | 139.35%210.33M | -150.65%-53.47M | -47.38%87.88M | 1,285.24%105.57M | 421.32%167M | 112.26%7.62M |
Cash from business operations | -1,281.59%-679.36M | 737.56%1.07B | -109.81%-49.17M | -53.62%128.27M | -29.07%501.32M | 192.90%276.56M | 177.71%706.76M | 56.44%-297.71M | -1,187.92%-909.45M | -507.48%-683.39M |
Hong Kong profits tax paid | ---- | -188.43%-6.15M | ---- | 654.26%6.96M | ---- | 88.19%-1.26M | ---- | ---10.63M | ---- | ---- |
China income tax paid | ---- | -198.18%-19.82M | ---- | ---6.65M | ---- | ---- | ---- | 56.96%-760K | ---- | ---1.77M |
Other taxs | ---- | 42.07%-8.82M | ---- | 11.87%-15.22M | ---- | -188.11%-17.27M | ---- | -281.60%-6M | ---- | 44.55%-1.57M |
Special items of business | -140.86%-63.1M | ---- | 35.11%154.45M | ---- | 287.03%114.31M | ---- | -67.94%29.54M | ---- | 73.76%92.12M | ---- |
Net cash from operations | -805.26%-742.46M | 817.05%1.04B | -82.90%105.27M | -56.07%113.36M | -16.39%615.64M | 181.89%258.03M | 190.08%736.29M | 54.12%-315.09M | -4,544.98%-817.33M | -554.58%-686.73M |
Cash flow from investment activities | ||||||||||
Interest received - investment | 213.51%16.59M | 118.45%12.99M | 1,130.93%5.29M | 271.46%5.95M | -70.69%430K | -83.16%1.6M | -52.52%1.47M | -62.43%9.51M | -73.57%3.09M | 3.97%25.31M |
Dividend received - investment | -14.44%448.79M | 17.58%485.84M | 34.35%524.51M | 1,046.17%413.21M | 982.93%390.41M | 115.44%36.05M | 115.44%36.05M | 15.49%16.73M | 15.49%16.73M | --14.49M |
Sale of fixed assets | ---- | ---- | ---- | ---- | --10K | ---- | ---- | ---- | ---- | ---- |
Purchase of fixed assets | -14.29%-16K | 93.94%-36K | 97.34%-14K | -51.15%-594K | ---527K | 25.00%-393K | ---- | -539.02%-524K | -393.33%-74K | -43.86%-82K |
Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---3.37B | ---- | ---- | ---- | ---66.34M |
Other items in the investment business | ---- | ---- | ---- | --2K | ---- | ---- | ---- | ---- | ---- | ---- |
Net cash from investment operations | -12.16%465.37M | 19.17%498.79M | 35.73%529.79M | 112.54%418.56M | 940.35%390.32M | -13,074.38%-3.34B | 89.96%37.52M | 196.60%25.72M | 149.17%19.75M | -209.64%-26.62M |
Net cash before financing | -143.63%-277.09M | 189.21%1.54B | -36.87%635.06M | 117.28%531.92M | 30.00%1.01B | -963.94%-3.08B | 197.02%773.81M | 59.43%-289.37M | -1,280.71%-797.58M | -506.82%-713.35M |
Cash flow from financing activities | ||||||||||
New borrowing | 1,054.18%1.33B | -84.42%366.64M | 111.75%114.89M | -6.46%2.35B | -86.01%54.26M | 51.22%2.52B | -57.35%387.75M | 95.60%1.66B | 3,244.84%909.13M | 410.19%850.69M |
Refund | -631.70%-348.98M | 66.22%-1.01B | 94.14%-47.69M | -107.96%-2.98B | 21.51%-814.25M | -85.36%-1.43B | -60.84%-1.04B | -46.38%-772.25M | -66.56%-644.98M | -48.82%-527.56M |
Issuing shares | ---- | ---- | ---- | --776.34M | --799.62M | ---- | ---- | ---- | ---- | ---- |
Interest paid - financing | -13.82%-25.95M | -82.76%-124.6M | 5.86%-22.8M | -28.66%-68.18M | -23.21%-24.22M | -40.39%-52.99M | -5.67%-19.65M | -88.04%-37.75M | -64.98%-18.6M | 37.80%-20.07M |
Dividends paid - financing | ---- | ---- | ---- | ---- | ---- | 50.00%-33M | ---- | -100.00%-66.01M | ---- | -150.00%-33M |
Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --288.49M | ---- |
Other items of the financing business | ---- | 52.21%534.17M | ---- | -64.34%350.95M | --158.17M | --984.2M | ---- | ---- | ---- | ---- |
Net cash from financing operations | 404.27%416.23M | -5.82%-581.91M | -179.22%-136.8M | -127.76%-549.91M | 125.77%172.69M | 152.06%1.98B | -225.74%-670.22M | 193.18%785.98M | 243.23%533.01M | 214.95%268.09M |
Effect of rate | 53.54%-16.05M | 177.10%8.41M | -383.25%-34.56M | -352.21%-10.91M | 608.07%12.2M | 291.05%4.33M | 600.87%1.72M | 210.27%1.11M | -133.86%-344K | 23.78%-1M |
Net Cash | -72.08%139.14M | 5,415.03%956.44M | -57.73%498.27M | 98.36%-18M | 1,037.77%1.18B | -321.01%-1.1B | 139.15%103.59M | 211.53%496.61M | 38.46%-264.58M | -669.44%-445.26M |
Begining period cash | 1,841.67%1.02B | -35.55%52.39M | -35.55%52.39M | -93.08%81.29M | -93.08%81.29M | 73.54%1.17B | 73.54%1.17B | -39.74%676.79M | -39.74%676.79M | -5.01%1.12B |
Cash at the end | 120.95%1.14B | 1,841.67%1.02B | -59.43%516.1M | -35.55%52.39M | -0.60%1.27B | -93.08%81.29M | 210.73%1.28B | 73.54%1.17B | -40.67%411.87M | -39.74%676.79M |
Cash balance analysis | ||||||||||
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Shin-Ei Zhonghe (Hong Kong) Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.